An Integrative Analysis Identifying RAB40C as an Oncogenic Immune Protein and Prognostic Marker of Lung Squamous Cell Carcinoma.

Pharmgenomics Pers Med · 2022 · PMC9135582 · PMID 35645578

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an elevated trendno p-value reported

RAB40C expression in BRCA, COAD, LUSC, TGCT, CHOL, uveal melanoma (UVM), and HNSC showed an elevated trend, but the differences with the normal tissues were not statistically significant ( Supplementary Figure 2 ).

also in 278 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.